Risk of early virological failure of once-daily tenofovir-emtricitabine plus twice-daily nevirapine in antiretroviral therapy-naive HIV-infected patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples